Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Wada

Showing results (811-820 of 844) with videos related to

Pageof 85
Sort By:
Nature|September 11, 2024
Cooling positronium to ultralow velocities with a chirped laser pulse trainK Shu, Y Tajima, R Uozumi, et al.
Bioorganic & Medicinal Chemistry Letters|November 1, 2003
Heterocyclic ketones as inhibitors of histone deacetylaseAnil Vasudevan, Zhiqin Ji, Robin R Frey, et al.
Journal of Enzyme Inhibition|October 28, 1999
Evaluation of the inhibition of other metalloproteinases by matrix metalloproteinase inhibitorsP A Marcotte, I N Elmore, Z Guan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 26, 2023
Eflornithine as Postimmunotherapy Maintenance in High-Risk Neuroblastoma: Externally Controlled, Propensity Score-Matched Survival Outcome ComparisonsJavier Oesterheld, William Ferguson, Jacqueline M Kraveka, et al.
International Journal of Cancer|May 12, 2020
A subset analysis of a phase II trial evaluating the use of DFMO as maintenance therapy for high-risk neuroblastomaElizabeth C Lewis, Jacqueline M Kraveka, William Ferguson, et al.
International Journal of Cancer|May 29, 2023
A phase II trial of nifurtimox combined with topotecan and cyclophosphamide for refractory or relapsed neuroblastoma and medulloblastomaDon Eslin, Peter E Zage, Genevieve Bergendahl, et al.
Epilepsy Research|March 27, 1999
Congenital malformations due to antiepileptic drugsS Kaneko, D Battino, E Andermann, et al.
Bioorganic & Medicinal Chemistry Letters|June 20, 2001
Biaryl ether retrohydroxamates as potent, long-lived, orally bioavailable MMP inhibitorsM R Michaelides, J F Dellaria, J Gong, et al.
Scientific Reports|September 29, 2018
Maintenance DFMO Increases Survival in High Risk NeuroblastomaGiselle L Saulnier Sholler, William Ferguson, Genevieve Bergendahl, et al.
The Japanese Journal of Antibiotics|January 1, 1996
[Susceptibilities of bacteria isolated from patients with respiratory infectious diseases to antibiotics (1992)]H Ikemoto, K Watanabe, T Mori, et al.
Pageof 85

Showing results (811-820 of 844) with videos related to

Sort By:
Pageof 85
Nature|September 11, 2024
Cooling positronium to ultralow velocities with a chirped laser pulse trainK Shu, Y Tajima, R Uozumi, et al.
Bioorganic & Medicinal Chemistry Letters|November 1, 2003
Heterocyclic ketones as inhibitors of histone deacetylaseAnil Vasudevan, Zhiqin Ji, Robin R Frey, et al.
Journal of Enzyme Inhibition|October 28, 1999
Evaluation of the inhibition of other metalloproteinases by matrix metalloproteinase inhibitorsP A Marcotte, I N Elmore, Z Guan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 26, 2023
Eflornithine as Postimmunotherapy Maintenance in High-Risk Neuroblastoma: Externally Controlled, Propensity Score-Matched Survival Outcome ComparisonsJavier Oesterheld, William Ferguson, Jacqueline M Kraveka, et al.
International Journal of Cancer|May 12, 2020
A subset analysis of a phase II trial evaluating the use of DFMO as maintenance therapy for high-risk neuroblastomaElizabeth C Lewis, Jacqueline M Kraveka, William Ferguson, et al.
International Journal of Cancer|May 29, 2023
A phase II trial of nifurtimox combined with topotecan and cyclophosphamide for refractory or relapsed neuroblastoma and medulloblastomaDon Eslin, Peter E Zage, Genevieve Bergendahl, et al.
Epilepsy Research|March 27, 1999
Congenital malformations due to antiepileptic drugsS Kaneko, D Battino, E Andermann, et al.
Bioorganic & Medicinal Chemistry Letters|June 20, 2001
Biaryl ether retrohydroxamates as potent, long-lived, orally bioavailable MMP inhibitorsM R Michaelides, J F Dellaria, J Gong, et al.
Scientific Reports|September 29, 2018
Maintenance DFMO Increases Survival in High Risk NeuroblastomaGiselle L Saulnier Sholler, William Ferguson, Genevieve Bergendahl, et al.
The Japanese Journal of Antibiotics|January 1, 1996
[Susceptibilities of bacteria isolated from patients with respiratory infectious diseases to antibiotics (1992)]H Ikemoto, K Watanabe, T Mori, et al.
Pageof 85